| Ezetimibe added to statin therapy after acute coronary syndromes CP Cannon, MA Blazing, RP Giugliano, A McCagg, JA White, P Theroux, ... New England Journal of Medicine 372 (25), 2387-2397, 2015 | 4920 | 2015 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1224 | 2017 |
| COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies D Atri, HK Siddiqi, JP Lang, V Nauffal, DA Morrow, EA Bohula Basic to Translational Science 5 (5), 518-536, 2020 | 442* | 2020 |
| The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript EA Bohula, AJ Salisbury, M Sohail, MP Playford, J Riedemann, ... Journal of Biological chemistry 278 (18), 15991-15997, 2003 | 351 | 2003 |
| Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved … RP Giugliano, CP Cannon, MA Blazing, JC Nicolau, R Corbalán, J Špinar, ... Circulation 137 (15), 1571-1582, 2018 | 347 | 2018 |
| Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and … EA Bohula, RP Giugliano, CP Cannon, J Zhou, SA Murphy, JA White, ... Circulation 132 (13), 1224-1233, 2015 | 338 | 2015 |
| Impact of renal function on outcomes with edoxaban in the ENGAGE AF-TIMI 48 trial EA Bohula, RP Giugliano, CT Ruff, JF Kuder, SA Murphy, EM Antman, ... Circulation 134 (1), 24-36, 2016 | 315 | 2016 |
| Epidemiology of shock in contemporary cardiac intensive care units: data from the critical care cardiology trials network registry DD Berg, EA Bohula, S Van Diepen, JN Katz, CL Alviar, VM Baird-Zars, ... Circulation: Cardiovascular Quality and Outcomes 12 (3), e005618, 2019 | 313 | 2019 |
| Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome: the IMPROVE-IT trial SA Murphy, CP Cannon, MA Blazing, RP Giugliano, JA White, ... Journal of the American College of Cardiology 67 (4), 353-361, 2016 | 298 | 2016 |
| Cardiovascular safety of lorcaserin in overweight or obese patients EA Bohula, SD Wiviott, DK McGuire, SE Inzucchi, J Kuder, KA Im, ... New England Journal of Medicine 379 (12), 1107-1117, 2018 | 265 | 2018 |
| Inflammatory and cholesterol risk in the FOURIER trial EA Bohula, RP Giugliano, LA Leiter, S Verma, JG Park, PS Sever, ... Circulation 138 (2), 131-140, 2018 | 255 | 2018 |
| Atherothrombotic risk stratification and ezetimibe for secondary prevention EA Bohula, DA Morrow, RP Giugliano, MA Blazing, P He, JG Park, ... Journal of the American College of Cardiology 69 (8), 911-921, 2017 | 205 | 2017 |
| Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction EA Bohula, MP Bonaca, E Braunwald, PE Aylward, R Corbalan, ... Circulation 134 (4), 304-313, 2016 | 187 | 2016 |
| Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by … AP Carnicelli, H Hong, SJ Connolly, J Eikelboom, RP Giugliano, ... Circulation 145 (4), 242-255, 2022 | 186 | 2022 |
| Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase VM Macaulay, AJ Salisbury, EA Bohula, MP Playford, NI Smorodinsky, ... Oncogene 20 (30), 4029-4040, 2001 | 163 | 2001 |
| Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the Critical Care Cardiology Trials Network Prospective North American … EA Bohula, JN Katz, S Van Diepen, CL Alviar, VM Baird-Zars, JG Park, ... JAMA cardiology 4 (9), 928-935, 2019 | 155 | 2019 |
| Stroke prevention with the PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitor evolocumab added to statin in high-risk patients with stable atherosclerosis RP Giugliano, TR Pedersen, JL Saver, PS Sever, AC Keech, EA Bohula, ... Stroke 51 (5), 1546-1554, 2020 | 138 | 2020 |
| A current review of COVID-19 for the cardiovascular specialist JP Lang, X Wang, FA Moura, HK Siddiqi, DA Morrow, EA Bohula American heart journal 226, 29-44, 2020 | 135 | 2020 |
| Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy … EA Bohula, SD Wiviott, RP Giugliano, MA Blazing, JG Park, SA Murphy, ... Circulation 136 (25), 2440-2450, 2017 | 134 | 2017 |
| Management and outcomes of cardiogenic shock in cardiac ICUs with versus without shock teams AI Papolos, BB Kenigsberg, DD Berg, CL Alviar, E Bohula, JA Burke, ... Journal of the American College of Cardiology 78 (13), 1309-1317, 2021 | 122 | 2021 |
